Planned Exelixis (EXEL) sale of 34,278 shares via Morgan Stanley

Rhea-AI Filing Summary

Exelixis has a planned Rule 144 sale of 34,278 common shares, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The filing lists an aggregate market value of 1,473,964.28 for these shares.

The shares were acquired as performance shares from the issuer on 01/15/2026, with the same date shown for payment and the nature of payment marked "Not Applicable." The document notes 259,708,689 shares outstanding, giving context for the size of this potential sale, and indicates an approximate sale date of 02/13/2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	34278	1473964.28	259708689	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Performance Shares	Issuer			34278	01/15/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the size of the planned Rule 144 share sale for EXEL?

The planned Rule 144 transaction covers 34,278 shares of Exelixis common stock, with an aggregate market value of 1,473,964.28. The filing also cites 259,708,689 shares outstanding, providing context for how small this sale is relative to total shares.

When and where are the EXEL shares expected to be sold?

The notice lists an approximate sale date of 02/13/2026 for the Exelixis shares. The planned sale is to be executed on the NASDAQ exchange through Morgan Stanley Smith Barney LLC Executive Financial Services, based in New York.

How were the EXEL shares in this Rule 144 filing acquired?

The 34,278 Exelixis shares to be sold were acquired as performance shares from the issuer on 01/15/2026. The filing shows the same date for payment, and the nature of payment is described as "Not Applicable" in the disclosure.

What broker is handling the planned EXEL Rule 144 sale?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker handling the transaction. Its address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, and the sale is to occur on NASDAQ.

What does the Rule 144 representation in the EXEL notice state?

The notice states that the person for whose account the securities are sold does not know any material adverse information about Exelixis’s operations that has not been publicly disclosed, reaffirming Rule 144’s emphasis on transparency and publicly available information.